According to IMARC Group latest report titled “Albumin Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028”, offers a comprehensive analysis of the industry, which comprises insights on albumin market size. The report also includes competitor and regional analysis, and contemporary advancements in the global market. The global albumin market size reached US$ 5.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 8.2 Billion by 2028, exhibiting a growth rate (CAGR) of 6.05% during 2023-2028.
Albumin refers to a water-soluble globular protein produced by the liver and found in blood plasma. It is synthesized in the liver and plays a vital role in maintaining the osmotic pressure, transport, and distribution of essential substances throughout the body. It contributes significantly to the regulation of fluid balance between the blood vessels and surrounding tissues. Its osmotic pressure facilitates the movement of fluids across cell membranes, ensuring proper hydration and nutrient delivery to cells. Additionally, albumin serves as a reserve for amino acids, which are essential building blocks for protein synthesis. It is widely used as a blood volumizer to treat rare diseases, liver disorders, blood loss, shocks, surgical complications, and burns. Besides this, albumin finds extensive applications in manufacturing drug delivery systems, therapeutics, culture media, and vaccines.
Request to Get the Sample Report: https://www.imarcgroup.com/albumin-market/requestsample
Market Trends:
The increasing prevalence of chronic medical disorders among the masses is driving the global market. Moreover, the rising adoption of HSA in pharmaceutical preparations, such as drug formulations and vaccines, is acting as another growth-inducing factor. Apart from this, continual technological advancements in albumin production, such as improved purification techniques, recombinant albumin production, and genetic engineering, are providing a boost to the market. In line with this, researchers are continuously investigating the potential therapeutic uses of albumin, such as in drug delivery systems, tissue engineering, and wound healing, which is creating a positive market outlook. Other factors, including the introduction of albumin-based nanoparticles, along with extensive research and development (R&D) activities in the field of biotechnology, are projected to propel the market further.
Explore Full Report with Table of Contents: https://www.imarcgroup.com/albumin-market
Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
- Albumedix Ltd
- Biotest AG
- Celgene Corporation (Bristol-Myers Squibb Company)
- CSL Limited
- Grifols SA
- HiMedia Laboratories
- Medxbio Pte Ltd
- Merck KGaA
- Octapharma AG
- Takeda Pharmaceutical Company Limited
- Thermo Fisher Scientific Inc.
- Ventria Bioscience Inc
Albumin Market Segmentation:
Our report has categorized the market based on region, product, application and end use industry.
Breakup by Product:
- Human Serum Albumin
- Bovine Serum Albumin
- Recombinant Albumin
Breakup by Application:
- Therapeutics
- Drug Formulation and Vaccine
- Component of Media
- Others
Breakup by End User:
- Hospitals and Clinics
- Pharmaceutical and Biotechnology Companies
- Research Institutes
Breakup by Region:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key highlights of the report:
- Market Performance (2017-2022)
- Market Outlook (2023-2028)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe:- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
